A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Rezolute
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Pfizer
University of Iowa
Novartis